APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iopamidol Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Iopamidol Injection Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchIopamidol Injection Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Iopamidol Injection Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Iopamidol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iopamidol Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Iopamidol Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Iopamidol Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iopamidol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iopamidol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iopamidol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iopamidol Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iopamidol Injection market include Bracco Imaging, Sanochemia and BeiLu Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iopamidol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iopamidol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iopamidol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iopamidol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Iopamidol Injection Segment by Company

Bracco Imaging

Sanochemia

BeiLu Pharma

Iopamidol Injection Segment by Type

9 g I/ 30 mL

11.1 g I/ 30 mL

Others

Iopamidol Injection Segment by Application

Hospitals

Clinics

Iopamidol Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Iopamidol Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iopamidol Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iopamidol Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Iopamidol Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iopamidol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iopamidol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iopamidol Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iopamidol Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iopamidol Injection industry.

Chapter 3: Detailed analysis of Iopamidol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iopamidol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iopamidol Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iopamidol Injection Industry Trends Table 2. Iopamidol Injection Industry Drivers Table 3. Iopamidol Injection Industry Opportunities and Challenges Table 4. Iopamidol Injection Industry Restraints Table 5. Global Iopamidol Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iopamidol Injection Revenue Share by Company (2021-2026) Table 7. Global Iopamidol Injection Sales Volume by Company (K L) & (2021-2026) Table 8. Global Iopamidol Injection Sales Volume Share by Company (2021-2026) Table 9. Global Iopamidol Injection Average Price (US$/L) of Company (2021-2026) Table 10. Global Iopamidol Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iopamidol Injection Key Company Manufacturing Base & Headquarters Table 12. Global Iopamidol Injection Company, Product Type & Application Table 13. Global Iopamidol Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iopamidol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 9 g I/ 30 mL Table 18. Significant Companies of 11.1 g I/ 30 mL Table 19. Significant Companies of Others Table 20. Global Iopamidol Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 21. Global Iopamidol Injection Sales Volume by Type (2021-2026) & (K L) Table 22. Global Iopamidol Injection Sales Volume by Type (2027-2032) & (K L) Table 23. Global Iopamidol Injection Sales Volume Share by Type (2021-2026) Table 24. Global Iopamidol Injection Sales Volume Share by Type (2027-2032) Table 25. Global Iopamidol Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Iopamidol Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Iopamidol Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Iopamidol Injection Sales Value Share by Type (2021-2026) Table 29. Global Iopamidol Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Global Iopamidol Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 33. Global Iopamidol Injection Sales Volume by Application (2021-2026) & (K L) Table 34. Global Iopamidol Injection Sales Volume by Application (2027-2032) & (K L) Table 35. Global Iopamidol Injection Sales Volume Share by Application (2021-2026) Table 36. Global Iopamidol Injection Sales Volume Share by Application (2027-2032) Table 37. Global Iopamidol Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Iopamidol Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Iopamidol Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Iopamidol Injection Sales Value Share by Application (2021-2026) Table 41. Global Iopamidol Injection Sales Value Share by Application (2027-2032) Table 42. Global Iopamidol Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 43. Global Iopamidol Injection Sales by Region (2021-2026) & (K L) Table 44. Global Iopamidol Injection Sales Market Share by Region (2021-2026) Table 45. Global Iopamidol Injection Sales by Region (2027-2032) & (K L) Table 46. Global Iopamidol Injection Sales Market Share by Region (2027-2032) Table 47. Global Iopamidol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Iopamidol Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Iopamidol Injection Sales Value Share by Region (2021-2026) Table 50. Global Iopamidol Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Iopamidol Injection Sales Value Share by Region (2027-2032) Table 52. Global Iopamidol Injection Market Average Price (US$/L) by Region (2021-2026) Table 53. Global Iopamidol Injection Market Average Price (US$/L) by Region (2027-2032) Table 54. Global Iopamidol Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 55. Global Iopamidol Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Iopamidol Injection Sales by Country (2021-2026) & (K L) Table 57. Global Iopamidol Injection Sales Market Share by Country (2021-2026) Table 58. Global Iopamidol Injection Sales by Country (2027-2032) & (K L) Table 59. Global Iopamidol Injection Sales Market Share by Country (2027-2032) Table 60. Global Iopamidol Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Iopamidol Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Iopamidol Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Iopamidol Injection Sales Value Market Share by Country (2027-2032) Table 64. Bracco Imaging Company Information Table 65. Bracco Imaging Business Overview Table 66. Bracco Imaging Iopamidol Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 67. Bracco Imaging Iopamidol Injection Product Portfolio Table 68. Bracco Imaging Recent Development Table 69. Sanochemia Company Information Table 70. Sanochemia Business Overview Table 71. Sanochemia Iopamidol Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 72. Sanochemia Iopamidol Injection Product Portfolio Table 73. Sanochemia Recent Development Table 74. BeiLu Pharma Company Information Table 75. BeiLu Pharma Business Overview Table 76. BeiLu Pharma Iopamidol Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 77. BeiLu Pharma Iopamidol Injection Product Portfolio Table 78. BeiLu Pharma Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Iopamidol Injection Distributors List Table 82. Iopamidol Injection Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Iopamidol Injection Product Image Figure 2. Global Iopamidol Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iopamidol Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iopamidol Injection Sales (2021-2032) & (K L) Figure 5. Global Iopamidol Injection Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Iopamidol Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 9 g I/ 30 mL Image Figure 10. 11.1 g I/ 30 mL Image Figure 11. Others Image Figure 12. Global Iopamidol Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 13. Global Iopamidol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Iopamidol Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Iopamidol Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Iopamidol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Iopamidol Injection Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Global Iopamidol Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 21. Global Iopamidol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Iopamidol Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Iopamidol Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Iopamidol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Iopamidol Injection Sales Value Share by Application (2021-2032) Figure 26. Global Iopamidol Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 27. Global Iopamidol Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Iopamidol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Iopamidol Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Iopamidol Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Iopamidol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Iopamidol Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Iopamidol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Iopamidol Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Iopamidol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Iopamidol Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Iopamidol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Iopamidol Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Iopamidol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Iopamidol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Iopamidol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Iopamidol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iopamidol Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Iopamidol Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 9 g I/ 30 mL
  • 11.1 g I/ 30 mL
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Bracco Imaging
  • Sanochemia
  • BeiLu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iopamidol Injection Sales Value (2021-2032)
  4. 1.2.2 Global Iopamidol Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Iopamidol Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iopamidol Injection Market Dynamics
  1. 2.1 Iopamidol Injection Industry Trends
  2. 2.2 Iopamidol Injection Industry Drivers
  3. 2.3 Iopamidol Injection Industry Opportunities and Challenges
  4. 2.4 Iopamidol Injection Industry Restraints
3 Iopamidol Injection Market by Company
  1. 3.1 Global Iopamidol Injection Company Revenue Ranking in 2025
  2. 3.2 Global Iopamidol Injection Revenue by Company (2021-2026)
  3. 3.3 Global Iopamidol Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Iopamidol Injection Average Price by Company (2021-2026)
  5. 3.5 Global Iopamidol Injection Company Ranking (2024-2026)
  6. 3.6 Global Iopamidol Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Iopamidol Injection Company Product Type and Application
  8. 3.8 Global Iopamidol Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iopamidol Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iopamidol Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iopamidol Injection Market by Type
  1. 4.1 Iopamidol Injection Type Introduction
  2. 4.1.1 9 g I/ 30 mL
  3. 4.1.2 11.1 g I/ 30 mL
  4. 4.1.3 Others
  5. 4.2 Global Iopamidol Injection Sales Volume by Type
  6. 4.2.1 Global Iopamidol Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Iopamidol Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Iopamidol Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Iopamidol Injection Sales Value by Type
  10. 4.3.1 Global Iopamidol Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Iopamidol Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Iopamidol Injection Sales Value Share by Type (2021-2032)
5 Iopamidol Injection Market by Application
  1. 5.1 Iopamidol Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Iopamidol Injection Sales Volume by Application
  5. 5.2.1 Global Iopamidol Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Iopamidol Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Iopamidol Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Iopamidol Injection Sales Value by Application
  9. 5.3.1 Global Iopamidol Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Iopamidol Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Iopamidol Injection Sales Value Share by Application (2021-2032)
6 Iopamidol Injection Regional Sales and Value Analysis
  1. 6.1 Global Iopamidol Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iopamidol Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Iopamidol Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Iopamidol Injection Sales by Region (2027-2032)
  5. 6.3 Global Iopamidol Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iopamidol Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iopamidol Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iopamidol Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Iopamidol Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iopamidol Injection Sales Value (2021-2032)
  12. 6.6.2 North America Iopamidol Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iopamidol Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Iopamidol Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iopamidol Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iopamidol Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iopamidol Injection Sales Value (2021-2032)
  21. 6.9.2 South America Iopamidol Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iopamidol Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iopamidol Injection Sales Value Share by Country, 2025 VS 2032
7 Iopamidol Injection Country-level Sales and Value Analysis
  1. 7.1 Global Iopamidol Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iopamidol Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iopamidol Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Iopamidol Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Iopamidol Injection Sales by Country (2027-2032)
  6. 7.4 Global Iopamidol Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iopamidol Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iopamidol Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iopamidol Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iopamidol Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iopamidol Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iopamidol Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iopamidol Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iopamidol Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iopamidol Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iopamidol Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iopamidol Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iopamidol Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iopamidol Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iopamidol Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iopamidol Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iopamidol Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iopamidol Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iopamidol Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iopamidol Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iopamidol Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iopamidol Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iopamidol Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iopamidol Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iopamidol Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iopamidol Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iopamidol Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iopamidol Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iopamidol Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iopamidol Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iopamidol Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iopamidol Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iopamidol Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bracco Imaging
  2. 8.1.1 Bracco Imaging Company Information
  3. 8.1.2 Bracco Imaging Business Overview
  4. 8.1.3 Bracco Imaging Iopamidol Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bracco Imaging Iopamidol Injection Product Portfolio
  6. 8.1.5 Bracco Imaging Recent Developments
  7. 8.2 Sanochemia
  8. 8.2.1 Sanochemia Company Information
  9. 8.2.2 Sanochemia Business Overview
  10. 8.2.3 Sanochemia Iopamidol Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanochemia Iopamidol Injection Product Portfolio
  12. 8.2.5 Sanochemia Recent Developments
  13. 8.3 BeiLu Pharma
  14. 8.3.1 BeiLu Pharma Company Information
  15. 8.3.2 BeiLu Pharma Business Overview
  16. 8.3.3 BeiLu Pharma Iopamidol Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BeiLu Pharma Iopamidol Injection Product Portfolio
  18. 8.3.5 BeiLu Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iopamidol Injection Value Chain Analysis
  2. 9.1.1 Iopamidol Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iopamidol Injection Sales Mode & Process
  6. 9.2 Iopamidol Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iopamidol Injection Distributors
  9. 9.2.3 Iopamidol Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst